Eira, J., Magalhães, J., Macedo, N., Pero, M. E., Misgeld, T., Sousa, M. M., Bartolini, F., & Liz, M. A. (2021). Transthyretin Promotes Axon Growth via Regulation of Microtubule Dynamics and Tubulin Acetylation. Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.747699

Sommer, R. J., Kim, J. H., Szerlip, M., Chandhok, S., Sugeng, L., Cain, C., Kaplan, A. V., & Gray, W. A. (2021). Conformal Left Atrial Appendage Seal Device for Left Atrial Appendage Closure. JACC: Cardiovascular Interventions, 14(21), 2368–2374. https://doi.org/10.1016/j.jcin.2021.08.060

Platt, J. M., Jager, J., Patrick, M. E., Kloska, D., Schulenberg, J., Rutherford, C., & Keyes, K. M. (2021). Forecasting future prevalence and gender differences in binge drinking among young adults through 2040. Alcoholism: Clinical and Experimental Research, 45(10), 2069–2079. Portico. https://doi.org/10.1111/acer.14690

Swol, J., Brodie, D., Willers, A., Zakhary, B., Belezzo, J., Shinar, Z., Weingart, S. D., Haft, J. W., Lorusso, R., & Peek, G. J. (2021). Human factors in ECLS – A keystone for safety and quality – A narrative review for ECLS providers. Artificial Organs, 46(1), 40–49. Portico. https://doi.org/10.1111/aor.14095

Oldham, J. M., Lee, C. T., Wu, Z., Bowman, W. S., Pugashetti, J. V., Dao, N., Tonkin, J., Seede, H., Echt, G., Adegunsoye, A., Chua, F., Maher, T. M., Garcia, C. K., Strek, M. E., Newton, C. A., & Molyneaux, P. L. (2021). Lung function trajectory in progressive fibrosing interstitial lung disease. European Respiratory Journal, 59(6), 2101396. https://doi.org/10.1183/13993003.01396-2021

Silverberg, S. J. (2021). Primary hyperparathyroidism: management after unsuccessful parathyroid surgery. British Journal of Surgery, 108(12), 1400–1401. https://doi.org/10.1093/bjs/znab375

Api, A. M., Belsito, D., Botelho, D., Bruze, M., Burton, G. A., Buschmann, J., Cancellieri, M. A., Dagli, M. L., Date, M., Dekant, W., Deodhar, C., Fryer, A. D., Jones, L., Joshi, K., Kumar, M., Lapczynski, A., Lavelle, M., Lee, I., Liebler, D. C., … Tokura, Y. (2022). RIFM fragrance ingredient safety assessment, anethole (isomer unspecified), CAS Registry Number 104-46-1. Food and Chemical Toxicology, 159, 112645. https://doi.org/10.1016/j.fct.2021.112645

Li, Z., Zhou, X., Ran, S., & Wehrmeister, F. C. (2021). Social protection and the level and inequality of child mortality in 101 low- and middle-income countries: A statistical modelling analysis. Journal of Global Health, 11. https://doi.org/10.7189/jogh.11.04067

Miller, J., Khlevner, J., & Rodriguez, L. (2021). Upper Gastrointestinal Functional and Motility Disorders in Children. Pediatric Clinics of North America, 68(6), 1237–1253. https://doi.org/10.1016/j.pcl.2021.07.009

Arnold, S. D., Bakshi, N., Chang, Z., Ross, D., Abraham, A., Bhatia, M., Guilcher, G. M. T., Haight, A., Hsieh, M., Kasow, K. A., Lane, P. A., Meacham, L., Olowoselu, F. O., & Krishnamurti, L. (2021). Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR). Blood, 138(Supplement 1), 425–425. https://doi.org/10.1182/blood-2021-154280

Lue, J. K., Ma, H., Marchi, E., Spivack, J. H., & O’Connor, O. A. (2021). Peripheral T-Cell Lymphoma Involvement of the Central Nervous System: Impact of Novel Therapeutics on Clinical Outcomes. Blood, 138(Supplement 1), 2469–2469. https://doi.org/10.1182/blood-2021-144933

Sawires, A. N., Park, P. J., & Lenke, L. G. (2021). A narrative review of infection prevention techniques in adult and pediatric spinal deformity surgery. Journal of Spine Surgery, 7(3), 413–421. https://doi.org/10.21037/jss-21-10

Chakraborty, R., Yan, Y., & Royal, M. (2021). A Phase 1, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients with Relapsed or Refractory Multiple Myeloma. Blood, 138(Supplement 1), 4763–4763. https://doi.org/10.1182/blood-2021-150783

Pennesi, E., Brivio, E., Willemse, M. E., Huitema, A. D. R., Chandra, S., Vijayakumar, A., Van Der Velden, V. H. J., Beverloo, H. B., Durairaj, C., Viqueira, A., Ingrosso, A., Locatelli, F., Motwani, J., Bourquin, J.-P., Bautista Sirvent, F. J., Rizzari, C., Petit, A., Lancaster, D., Metzler, M., … Zwaan, C. M. (2021). A Phase I/II Study of Bosutinib in Pediatric Patients with Resistant/Intolerant or Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Study ITCC (Innovative Therapies for Children with Cancer European Consortium) 054 and COG (Children’s Oncology Group Consortium) AAML1921: Results from the Phase I Trial in Resistant/Intolerant Patients. Blood, 138(Supplement 1), 2558–2558. https://doi.org/10.1182/blood-2021-145709

Galan-Diez, M., Borot, F., Ali, A. M., Zhao, J., Gil-Iturbe, E., Shan, X., Huang, X.-P., Kurland, I., Roth, B. L., Quick, M., Mukherjee, S., Rabadan, R., Carroll, M. P., Raza, A., & Kousteni, S. (2021). A Targetable Bone Marrow-Niche Axis for the Treatment of Acute Myeloid Leukemia. Blood, 138(Supplement 1), 4456–4456. https://doi.org/10.1182/blood-2021-147741

Thompson, M. C., Roeker, L. E., Coombs, C. C., Jensen, J. L., Kamdar, M., Skarbnik, A., Pagel, J. M., Bailey, N., Pu, J. J., Jacobs, R., Hill, B. T., Brander, D. M., Shadman, M., Ujjani, C. S., Battiato, K. E., Komari, C. J., Sacchi De Camargo Correia, G., Aronson, J. H., Rhodes, J. M., … Mato, A. R. (2021). Addressing a New Challenge in Chronic Lymphocytic Leukemia: Outcomes of Therapies after Exposure to Both a Covalent Bruton’s Tyrosine Kinase Inhibitor and Venetoclax. Blood, 138(Supplement 1), 2628–2628. https://doi.org/10.1182/blood-2021-150751

Kadia, T. M., Pemmaraju, N., Yilmaz, M., Daver, N., Li, L., Lyu, M.-A., Huang, M., Zeng, K., Cook, R., Parmar, S., Mukherjee, S., Sadeghi, T., DiNardo, C. D., Issa, G. C., Jabbour, E. J., Borthakur, G., Jain, N., & Verstovsek, S. (2021). Adoptive Therapy with Allogeneic Cord Blood T Regulatory Cells Improves Transfusion Requirement in Bone Marrow Failure Syndromes. Blood, 138(Supplement 1), 3875–3875. https://doi.org/10.1182/blood-2021-153864

Au Yeung, K. H. R., Russell, V., Choi, W., Wong, A., Tsui, L., Lee, Y. Y. C., Li, J., Gill, H., Ip, H.-W., Kwong, Y. L., Dave, T., Ondrejka, S. L., Bhagat, G., Chadburn, A., Rutherford, S. C., Koff, J. L., Jaye, D. L., Czader, M., Louissaint, A., … Tse, E. (2021). ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis. Blood, 138(Supplement 1), 2403–2403. https://doi.org/10.1182/blood-2021-148807

Kitamoto, T., Kuo, T., Okabe, A., Kaneda, A., & Accili, D. (2021). An integrative transcriptional logic model of hepatic insulin resistance. Proceedings of the National Academy of Sciences, 118(45). https://doi.org/10.1073/pnas.2102222118

Li Bassi, G., Suen, J. Y., White, N., Dalton, H. J., Fanning, J., Corley, A., Shrapnel, S., Hinton, S., Forsyth, S., Parsons, R., Laffey, J. G., Fan, E., Bartlett, R., Brodie, D., Burrell, A., Chiumello, D., Elhazmi, A., Grasselli, G., … Hodgson, C. (2021). Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019: An International Cohort Study. Critical Care Explorations, 3(11), e0567. https://doi.org/10.1097/cce.0000000000000567

Koffman, Dr. B., Stewart, C., Avruch, L., Bailey, N., Brumble, R., Byrd, J. C., Danilov, A. V., Davids, M. S., Furman, R., Jain, N., Kay, N. E., Lamanna, N., Mato, A. R., Skarbnik, A., Ujjani, C. S., & Pagel, J. M. (2021). Awareness, Knowledge, and Preferences of United States (US) Patients with Chronic Lymphocytic Leukemia (CLL) and Their Caregivers Related to Finite Duration (FD) Therapy and Minimal (Measurable) Residual Disease (MRD). Blood, 138(Supplement 1), 1927–1927. https://doi.org/10.1182/blood-2021-145046

Mathew, J., Cerpa, M., Lee, N. J., Boddapati, V., Marciano, G., Sardar, Z. M., & Lenke, L. G. (2021). Comparing hyperlordotic and standard lordotic cages for achieving segmental lumbar lordosis during transforaminal lumbar interbody fusion in adult spinal deformity surgery. Journal of Spine Surgery, 7(3), 318–325. https://doi.org/10.21037/jss-21-15

Sarkaria, S. M., Bao, S., Zhang, C., & Ding, L. (2021). Comprehensive Cellular Dissection of the Bone Marrow Microenvironment in Primary Myelofibrosis. Blood, 138(Supplement 1), 200–200. https://doi.org/10.1182/blood-2021-153727

Ricker, E. C., Ryu, Y. K., & Amengual, J. E. (2021). Daratumumab Plus Chemotherapy Induces Complete Responses in a Consecutive Series of Four Patients with Plasmablastic Lymphoma. Blood, 138(Supplement 1), 4573–4573. https://doi.org/10.1182/blood-2021-150800

Albitar, M., Zhang, H., Goy, A. H., Xu-Monette, Z., Bhagat, G., Visco, C., Tzankov, A., Fang, X., Zhu, F., Dybkaer, K., Chiu, A., Tam, W., Zu, Y., Hsi, E. D., Hagemeister, F. B., Huh, J., Ponzoni, M., Ferreri, A. J. M., Moller, M., … Young, K. H. (2021). Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms. Blood, 138(Supplement 1), 2395–2395. https://doi.org/10.1182/blood-2021-148841

Ricker, E. C., Estrella, B., Pazos, M. A., & Amengual, J. E. (2021). Dual Targeting of EZH2 and HDAC with Tazemetostat and Belinostat Promotes Immunogenicity in GC-DLBCL. Blood, 138(Supplement 1), 2410–2410. https://doi.org/10.1182/blood-2021-153460

Zonder, J. A., Richter, J., Bumma, N., Brayer, J., Hoffman, J. E., Bensinger, W. I., Wu, K. L., Xu, L., Chokshi, D., Boyapati, A., Sharma, M., Rodriguez Lorenc, K., Kroog, G. S., Dhodapkar, M. V., Lentzsch, S., Cooper, D., & Jagannath, S. (2021). Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome with REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 First-in-Human Study in Patients with Relapsed/Refractory Multiple Myeloma (RRMM). Blood, 138(Supplement 1), 160–160. https://doi.org/10.1182/blood-2021-144921

Chiu, L., Shen, M., Lo, C.-H., Chiu, N., Chen, A., Shin, H. J., Prsic, E. H., Hur, C., Chow, R., & Lebwohl, B. (2021). Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis. PLOS ONE, 16(11), e0259514. https://doi.org/10.1371/journal.pone.0259514

Bahlis, N. J., Richard, S., White, D. J., Grosicki, S., Chen, C., Delimpasi, S., Sutherland, H. J., Maslyak, Z., Sebag, M., Gavriatopoulou, M., Lentzsch, S., Chari, A., Simonova, M., Spicka, I., Kriachok, I., Dimopoulos, M. A., Pylypenko, H., Auner, H. W., Leleu, X., … Richardson, P. G. (2021). Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd). Blood, 138(Supplement 1), 1634–1634. https://doi.org/10.1182/blood-2021-146324

Lentzsch, S., Lipe, B., Tuchman, S. A., Bahlis, N. J., Bensinger, W. I., Sebag, M., Sutherland, H. J., Monge, J., Gasparetto, C. J., Baljevic, M., Callander, N. S., Venner, C. P., White, D. J., Kotb, R., Chen, C. I., Schiller, G. J., Madan, S., Leblanc, R., DeCastro, A., … Biran, N. (2021). Efficacy and Safety of Selinexor-Containing Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies (αCD38 mAb). Blood, 138(Supplement 1), 1651–1651. https://doi.org/10.1182/blood-2021-150232

Shen, B. (2020). Endoscopic band ligation with hypertonic glucose cushion in the treatment of ileal pouch prolapse. Gastroenterology Report, 9(5), 480–482. https://doi.org/10.1093/gastro/goaa089

Eckhardt, C. M., & Wu, H. (2021). Environmental Exposures and Lung Aging: Molecular Mechanisms and Implications for Improving Respiratory Health. Current Environmental Health Reports, 8(4), 281–293. https://doi.org/10.1007/s40572-021-00328-2

Tremblay, D., Srisuwananukorn, A., Ronner, L., Podoltsev, N., Gotlib, J., Heaney, M. L., Kuykendall, A. T., O’Connell, C. L., Shammo, J. M., Fleischman, A., Mesa, R. A., Yacoub, A., Hoffman, R., Moshier, E., Zubizarreta, N., & Mascarenhas, J. (2021). European Leukemianet (ELN) Response Predicts Disease Progression but Not Thrombosis or Death in Polycythemia Vera (PV): An Analysis of a Multicenter Database. Blood, 138(Supplement 1), 240–240. https://doi.org/10.1182/blood-2021-148020

Youn, M., Smith, S. M., Lee, A. G., Chae, H.-D., Spiteri, E., Erdmann, J., Galperin, I., Murphy, L. C., Donato, M., Abidi, P., Bittencourt, H., Lacayo, N. J., Dahl, G., Aftandilian, C., Davis, K. L., Matthews, J. A., Kornblau, S. M., Huang, M., Sumarsono, N., … Sakamoto, K. M. (2021). Gene Expression Analysis of CML Patients across the Age Spectrum. Blood, 138(Supplement 1), 1473–1473. https://doi.org/10.1182/blood-2021-148701

Leeman-Neill, R. J., Thakkar, D., Ondrejka, S. L., Hsi, E. D., Chadburn, A., Mejia Saldarriaga, M., Rutherford, S. C., McCall, C. M., Aljurf, T., McKinney, M., Koff, J. L., Jaye, D. L., Cohen, J. B., Soliman, D. S., Louissaint, A., Ong, C. K., Cheng, C. L., Lee, L., Behdad, A., … Bhagat, G. (2021). Genomic and Transcriptional Characterization of Primary Mediastinal Large B Cell Lymphoma. Blood, 138(Supplement 1), 2398–2398. https://doi.org/10.1182/blood-2021-149745

Muchtar, E., Dispenzieri, A., Wisniowski, B., Palladini, G., Milani, P., Merlini, G., Schönland, S., Veelken, K., Hegenbart, U., Kumar, S., Kastritis, E., Dimopoulos, M. A., Liedtke, M., Witteles, R., Sanchorawala, V., Szalat, R., Landau, H. J., Petrlik, E., Lentzsch, S., … Gertz, M. A. (2021). Graded Cardiac Response Criteria for AL Amyloidosis: The Impact of Depth of Cardiac Response on Survival. Blood, 138(Supplement 1), 2720–2720. https://doi.org/10.1182/blood-2021-149222

Muchtar, E., Wisniowski, B., Palladini, G., Milani, P., Merlini, G., Schönland, S., Veelken, K., Hegenbart, U., Dispenzieri, A., Kumar, S., Leung, N., Kastritis, E., Dimopoulos, M. A., Liedtke, M., Witteles, R., Sanchorawala, V., Szalat, R., Landau, H. J., Petrlik, E., … Gertz, M. A. (2021). Graded Renal Response Criteria for Light Chain (AL) Amyloidosis. Blood, 138(Supplement 1), 2721–2721. https://doi.org/10.1182/blood-2021-149594

Lipsky, A. H., Hill, B. T., Winter, A. M., Jurcic, J. G., Heaney, M. L., Rosenblat, T. L., Chiaramonte, M., Weissbrot, H., & Lamanna, N. (2021). High Rates of Undetectable Minimal Residual Disease Remissions with Time-Limited Bendamustine, Rituximab, and Venetoclax (BR-VR) in Untreated Chronic Lymphocytic Leukemia (CLL). Blood, 138(Supplement 1), 1555–1555. https://doi.org/10.1182/blood-2021-150914

Estrella, B., Liu, Y., Ricker, E. C., Pazos, M. A., Fiorito, J., Zuccarello, E., Calcagno, E., Honig, B., Arancio, O., & Amengual, J. E. (2021). Histone Acetyltransferase (HAT) Activator, YF2, Modulates the p53:BCL6 Axis and Antigen Presentation in Diffuse Large B-Cell Lymphomas. Blood, 138(Supplement 1), 2254–2254. https://doi.org/10.1182/blood-2021-151442

Paolino, J. D., Flamand, Y., Stevenson, K. E., Koch, V., Athale, U. H., Cole, P. D., Gennarini, L. M., Kahn, J. M., Kelly, K. M., Laverdiere, C., Leclerc, J.-M., Michon, B., Place, A. E., Supko, J. G., Tran, T. H., Welch, J. J. G., Neuberg, D. S., Sallan, S. E., Silverman, L. B., & Vrooman, L. M. (2021). Impact of Age, Body Surface Area, and Body Mass Index on Pegaspargase Toxicity and Pharmacokinetics: A Report from the DFCI ALL Consortium. Blood, 138(Supplement 1), 3396–3396. https://doi.org/10.1182/blood-2021-151313

Park, J. H., Nikiforow, S., Kim, S., Hu, Z.-H., Moskop, A., Ahmed, S., Bilal Abid, M., Badar, T., Bredeson, C., Brown, V., Cairo, M. S., Díaz, M., Dholaria, B., Ganguly, S., Grover, N. S., Hanna, R., Hematti, P., Kohorst, M. A., Lazarus, H., … Perales, M.-A. (2021). Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL). Blood, 138(Supplement 1), 3880–3880. https://doi.org/10.1182/blood-2021-148652

Hopson, M., Bhutani, D., Sarkaria, S. M., Maurer, M., Griffin, J., Lentzsch, S., & Chakraborty, R. (2021). Impact of Light Chain Isotype on Clinical Features and Outcomes in Systemic AL Amyloidosis. Blood, 138(Supplement 1), 4726–4726. https://doi.org/10.1182/blood-2021-149299

Hill, B. T., Roth, C. J., Kositsky, R., Dave, T., Love, C., McKinney, M., Galal, A., Neff, J. L., Mian, A., Kendall, E., Ondrejka, S. L., Chiaramonte, M., Bhagat, G., Ofori, K., Reshef, R., Kovach, A. E., Sethi, T., Mason, E. F., Bhaskar, S., … Dave, S. S. (2021). Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy. Blood, 138(Supplement 1), 165–165. https://doi.org/10.1182/blood-2021-145764

Pemmaraju, N., Kantarjian, H., Sweet, K., Wang, E. S., Lane, A. A., Ali, H., Stein, A. S., Yacoub, A., Rizzieri, D. A., Vasu, S., Gupta, V., Lee, S., Schiller, G. J., Foran, J. M., Taparia, M. S., Rosenblat, T. L., Walter, R. B., Sieminski, D., Anant, M., … Konopleva, M. (2021). Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients with Hematologic Malignancies. Blood, 138(Supplement 1), 2318–2318. https://doi.org/10.1182/blood-2021-145344

Batlevi, C. L., Park, S. I., Nastoupil, L., Phillips, T., Amengual, J. E., Andorsky, D., Campbell, P., McKay, P., Pagel, J. M., Leonard, J. P., Yang, J., O’Connor, H., Hamlett, A., Adib, D., & Morschhauser, F. (2021). Interim Analysis of the Randomized Phase 1b/3 Study Evaluating the Safety and Efficacy of Tazemetostat Plus Lenalidomide and Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma. Blood, 138(Supplement 1), 2207–2207. https://doi.org/10.1182/blood-2021-148199

Kahn, J. M., Bo-Subait, S., Buchbinder, D. K., Hamilton, B. K., Schoemans, H., Brazauskas, R., Phelan, R., & Satwani, P. (2021). Late Effects after Allogeneic Hematopoietic Cell Transplantation Among Children and Adolescents with Non-Malignant Disorders: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Blood, 138(Supplement 1), 412–412. https://doi.org/10.1182/blood-2021-151446

Neelapu, S. S., Chavez, J. C., Sehgal, A. R., Epperla, N., Ulrickson, M. L., Bachy, E., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Oluwole, O. O., Yakoub-Agha, I., Khanal, R., Rosenblatt, J. D., Sherman, M., Dong, J., Giovanetti, A., … Jacobson, C. (2021). Long-Term Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL). Blood, 138(Supplement 1), 93–93. https://doi.org/10.1182/blood-2021-148473

Li, S., Fu, J., Yang, J., Ma, H., Mapara, M. Y., Marcireau, C., & Lentzsch, S. (2021). MAP4K2 Silencing Overcomes IMiDs-Resistance in Multiple Myeloma. Blood, 138(Supplement 1), 2662–2662. https://doi.org/10.1182/blood-2021-151844

Veludhandi, A., John, T. D., Bakshi, N., Arnold, S. D., Bhatia, M., Lane, P. A., Meacham, L., Khemani, K., Chaudhury, S., Olowoselu, F. O., Kasow, K. A., Hsieh, M., Abraham, A., Guilcher, G. M. T., & Krishnamurti, L. (2021). Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR). Blood, 138(Supplement 1), 3030–3030. https://doi.org/10.1182/blood-2021-152383

De Botton, S., Yee, K., Recher, C., Wei, A. H., Montesinos, P., Taussig, D., Pigneux, A., Braun, T., Curti, A., Esteve, J., Grove, C., Jonas, B. A., Khwaja, A., Legrand, O., Peterlin, P., Arnan Sangerman, M., Blum, W. G., Cilloni, D., Hiwase, D., … Fenaux, P. (2021). Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia. Blood, 138(Supplement 1), 2351–2351. https://doi.org/10.1182/blood-2021-144912